Omega Diagnostics highlights positive study data for COVID-19 antigen test By Investing.com
By Samuel Indyk Investing.com – Omega Diagnostics (LON:ODX) has said that a study of its Mologic lateral flow antigen test has provided “positive” results. The study, titled “Accuracy of the Mologic COVID-19 rapid antigen test: a prospective multi-centre analytical and clinical evaluation”, concluded that the Mologic test has fulfilled the World Health Organization target diagnostic accuracy with a high sensitivity (93.2%-98.4%) detecting individuals with high viral load infections. “This is great news for the Mologic test, which we are now producing under our VISITECT brand,” said Omega Diagnostics CEO Colin King. “It is significant that the...
Continue reading